Black Rose Industries delivered a robust financial performance in the first quarter of FY27, with standalone net profit after tax (PAT) surging 146% year-on-year to ₹10.4 crore. The Mumbai-based chemical manufacturer and distributor posted total revenue of ₹90.1 crore for the quarter ended June 30, 2026, up 48% from ₹60.9 crore in Q1FY26. The earnings acceleration was primarily driven by a sharp expansion in its distribution business, which saw revenue more than double, alongside improved margins across key product categories. The Board of Directors declared an interim dividend of ₹2 per equity share, reflecting confidence in the company’s cash flow generation and operational leverage.

The Board meeting held on July 31, 2026, approved the unaudited financial results pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory Auditors M M Nissim & Co LLP issued an unmodified limited review report. The record date for dividend entitlement is fixed for August 6, 2026. Additionally, the Board reaffirmed the voluntary winding up of its wholly-owned Japanese subsidiary, B.R. Chemicals Co. Limited, which contributed nil turnover in the last financial year.

Segment-wise Performance

The distribution division emerged as the primary growth engine, contributing ₹62.7 crore to revenue, a significant jump from ₹32.8 crore in the corresponding quarter last year. This segment’s EBITDA expanded sharply to ₹10.5 crore from ₹1.8 crore, benefiting from higher sales realizations following market price rises post-West Asia conflict and healthy export volumes to the US oil & gas sector. Conversely, the manufacturing division reported resilient but flat revenue of ₹26.4 crore, similar to Q1FY26 levels, as sequential volumes moderated due to customer inventory adjustments. However, manufacturing EBITDA improved to ₹7.3 crore from ₹6.1 crore, supported by favorable pricing trends in solid acrylamide and better spreads in liquid acrylamide despite lower raw material costs.

Key Financial Indicators

The company’s financial health remained strong, with the debt-to-equity ratio improving to 0.001 from 0.006 in Q1FY26. The quarterly interest coverage ratio nearly doubled to 59.6 times from 29.2 times, indicating robust debt servicing capacity. Return on equity (ROE) climbed significantly to 23.2% from 11.0% year-ago. EBITDA margin expanded to 17.33% from 11.5%, while net profit margin rose to 11.68% from 7.1%. Inventory turnover improved to 1.16 times from 0.68 times, signaling efficient stock management.

What the Numbers Show

The disproportionate rise in profitability relative to revenue growth highlights a structural shift in Black Rose Industries’ earnings mix. With distribution revenue now constituting 2.38 times that of manufacturing (up from 1.22 times), the company is increasingly leveraging its stock-and-sale model to capture margin expansion during periods of price volatility. While sequential revenue declined by 14% from the elevated base of Q4FY26, the ability to maintain EBITDA growth of 12% demonstrates effective cost control and pricing power. The near-zero debt position and high interest coverage ratio provide ample financial flexibility for upcoming capacity expansions, including the piloting of Polyacrylamide (PAM) solid projects and potential collaboration with Koei Chemical Company, Ltd. for specialty amines.

Black Rose Industries company name reported a standalone net profit of ₹1,040.65 lakh for the quarter ended June 30, 2026, up from ₹424.17 lakh in the same period of FY25. The surge in profitability was driven by a robust rise in revenue from operations, which climbed to ₹8,908.07 lakh compared to ₹5,984.95 lakh in Q1FY25. This performance underscores improved operational efficiency and demand strength in the company’s core segments.

The Board of Directors approved the unaudited financial results at its meeting held on July 31, 2026, following a review by the Audit Committee. The results were filed with stock exchanges pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A corrigendum was subsequently issued on August 2, 2026, and August 3, 2026, to correct column headings in the initial newspaper publication, clarifying that the comparative data referred to the quarter ended March 31, 2026, rather than the full year.

Financial Highlights

Consolidated figures mirrored the standalone performance, with total income from operations standing at ₹8,908.07 lakh. The net profit after tax for consolidated operations remained at ₹1,040.65 lakh. Discontinued operations resulted in a negligible loss of ₹1.72 lakh in the consolidated statement.

Dividend Declaration

In a move rewarding shareholders, the Board declared an interim dividend of ₹2 per equity share, equivalent to 200% of the paid-up equity share capital. The record date for determining dividend entitlement has been fixed as August 6, 2026. This declaration reflects the company’s strong cash generation capabilities during the quarter.

What the Numbers Show

The disproportionate growth in net profit relative to revenue indicates significant margin expansion. While revenue grew by approximately 49%, pre-tax profits surged by over 144%. This divergence suggests effective cost management or a favorable shift in product mix during the quarter. The earnings per share more than doubled to ₹2.04 from ₹0.83, directly benefiting equity holders.